These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30779679)

  • 41. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
    Lumry WR
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
    Bernstein DI; Teper A; Gopalan G; Gates D
    Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?
    Yawn B
    MedGenMed; 2006 Jan; 8(1):23. PubMed ID: 16915153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey.
    Ganesh V; Banigo A; McMurran AEL; Shakeel M; Ram B
    J Laryngol Otol; 2017 Nov; 131(11):991-996. PubMed ID: 29050548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OTC fluticason nasal spray for allergic rhinitis.
    Med Lett Drugs Ther; 2015 Mar; 57(1465):48-9. PubMed ID: 25853580
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: A systematic review and meta-analysis.
    Juel-Berg N; Darling P; Bolvig J; Foss-Skiftesvik MH; Halken S; Winther L; Hansen KS; Askjaer N; Heegaard S; Madsen AR; Opstrup MS
    Am J Rhinol Allergy; 2017 Jan; 31(1):19-28. PubMed ID: 28234147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Question: Nasal saline or intranasal corticosteroids to treat allergic rhinitis in children.
    Madison S; Brown EA; Franklin R; Wickersham EA; McCarthy LH
    J Okla State Med Assoc; 2016; 109(4-5):152-3. PubMed ID: 27328556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Capsaicin for non-allergic rhinitis.
    Gevorgyan A; Segboer C; Gorissen R; van Drunen CM; Fokkens W
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010591. PubMed ID: 26171907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis.
    Bryson HM; Faulds D
    Drugs; 1992 May; 43(5):760-75. PubMed ID: 1379151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
    Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
    Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
    Berger W; Sher E; Gawchik S; Fineman S
    Allergy Asthma Proc; 2018 Mar; 39(2):110-116. PubMed ID: 29490769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study.
    LaForce C; Journeay GE; Miller SD; Silvey MJ; Wu W; Lee LA; Chylack LT
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):45-50. PubMed ID: 23806459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis.
    Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
    Int Forum Allergy Rhinol; 2018 Dec; 8(12):1445-1453. PubMed ID: 30054985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
    Derendorf H; Meltzer EO
    Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients.
    Emanuel IA; Blaiss MS; Meltzer EO; Evans P; Connor A
    Am J Rhinol Allergy; 2014; 28(2):117-21. PubMed ID: 24598007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
    Schenkel EJ; Skoner DP; Bronsky EA; Miller SD; Pearlman DS; Rooklin A; Rosen JP; Ruff ME; Vandewalker ML; Wanderer A; Damaraju CV; Nolop KB; Mesarina-Wicki B
    Pediatrics; 2000 Feb; 105(2):E22. PubMed ID: 10654982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corticosteroids in the treatment of pediatric allergic rhinitis.
    Scadding GK
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S59-64. PubMed ID: 11449208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and tolerability of treatments for allergic rhinitis in children.
    Baena-Cagnani CE
    Drug Saf; 2004; 27(12):883-98. PubMed ID: 15366976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis.
    Wiseman LR; Benfield P
    Drugs; 1997 May; 53(5):885-907. PubMed ID: 9129872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.